Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography Study
Aim: We sought to identify markers of motor and nonmotor function in Parkinson's disease (PD) using advanced neuroimaging techniques in subjects with PD. Methods: We enrolled 26 nondemented PD subjects and 12 control subjects. All subjects underwent [ 18 F]fluorodeoxyglucose positron emission c...
Saved in:
Published in | Dementia and geriatric cognitive disorders Vol. 35; no. 3-4; pp. 183 - 196 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
Karger
01.01.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim: We sought to identify markers of motor and nonmotor function in Parkinson's disease (PD) using advanced neuroimaging techniques in subjects with PD. Methods: We enrolled 26 nondemented PD subjects and 12 control subjects. All subjects underwent [ 18 F]fluorodeoxyglucose positron emission computed tomography (FDG-PET) and magnetic resonance imaging, and a complete neuropsychological battery. Results: FDG-PET of subjects with PD revealed significant metabolic elevations in the bilateral posterior lentiform nucleus, posterior cingulate, and parahippocampus, and metabolic reductions in the bilateral temporoparietal association cortex and occipital lobe versus controls. PD subjects had significant reductions in executive/attention function, memory/verbal learning, and speed of thinking, and significantly increased depression, anxiety and apathy scores compared with controls. Motor dysfunction correlated with increased metabolism in the posterior lentiform nucleus, pons, and cerebellum, and decreased metabolism in the temporoparietal lobe. Cognitive dysfunction correlated with increased posterior cingulate metabolism and decreased temporoparietal lobe metabolism. Depressive symptoms correlated with increased amygdala metabolism; anxiety scores correlated with decreased caudate metabolism, and apathy scores correlated with increased metabolism in the anterior cingulate and orbitofrontal lobe and decreased metabolism in the temporoparietal association cortex. Conclusions: Our findings showed that motor, cognitive, and emotional dysfunction in PD are associated with distinct patterns of cerebral metabolic changes. |
---|---|
AbstractList | Aim: We sought to identify markers of motor and nonmotor function in Parkinson's disease (PD) using advanced neuroimaging techniques in subjects with PD. Methods: We enrolled 26 nondemented PD subjects and 12 control subjects. All subjects underwent [18F]fluorodeoxyglucose positron emission computed tomography (FDG-PET) and magnetic resonance imaging, and a complete neuropsychological battery. Results: FDG-PET of subjects with PD revealed significant metabolic elevations in the bilateral posterior lentiform nucleus, posterior cingulate, and parahippocampus, and metabolic reductions in the bilateral temporoparietal association cortex and occipital lobe versus controls. PD subjects had significant reductions in executive/attention function, memory/verbal learning, and speed of thinking, and significantly increased depression, anxiety and apathy scores compared with controls. Motor dysfunction correlated with increased metabolism in the posterior lentiform nucleus, pons, and cerebellum, and decreased metabolism in the temporoparietal lobe. Cognitive dysfunction correlated with increased posterior cingulate metabolism and decreased temporoparietal lobe metabolism. Depressive symptoms correlated with increased amygdala metabolism; anxiety scores correlated with decreased caudate metabolism, and apathy scores correlated with increased metabolism in the anterior cingulate and orbitofrontal lobe and decreased metabolism in the temporoparietal association cortex. Conclusions: Our findings showed that motor, cognitive, and emotional dysfunction in PD are associated with distinct patterns of cerebral metabolic changes. Aim: We sought to identify markers of motor and nonmotor function in Parkinson's disease (PD) using advanced neuroimaging techniques in subjects with PD. Methods: We enrolled 26 nondemented PD subjects and 12 control subjects. All subjects underwent [ 18 F]fluorodeoxyglucose positron emission computed tomography (FDG-PET) and magnetic resonance imaging, and a complete neuropsychological battery. Results: FDG-PET of subjects with PD revealed significant metabolic elevations in the bilateral posterior lentiform nucleus, posterior cingulate, and parahippocampus, and metabolic reductions in the bilateral temporoparietal association cortex and occipital lobe versus controls. PD subjects had significant reductions in executive/attention function, memory/verbal learning, and speed of thinking, and significantly increased depression, anxiety and apathy scores compared with controls. Motor dysfunction correlated with increased metabolism in the posterior lentiform nucleus, pons, and cerebellum, and decreased metabolism in the temporoparietal lobe. Cognitive dysfunction correlated with increased posterior cingulate metabolism and decreased temporoparietal lobe metabolism. Depressive symptoms correlated with increased amygdala metabolism; anxiety scores correlated with decreased caudate metabolism, and apathy scores correlated with increased metabolism in the anterior cingulate and orbitofrontal lobe and decreased metabolism in the temporoparietal association cortex. Conclusions: Our findings showed that motor, cognitive, and emotional dysfunction in PD are associated with distinct patterns of cerebral metabolic changes. |
Author | Huang, Chaorui Piboolnurak, Panida Solnes, Lilja Dorfman, Benjamin J. Maniscalco, James S. Severt, Lawrence Ravdin, Lisa D. Henchcliffe, Claire Nirenberg, Melissa J. |
Author_xml | – sequence: 1 givenname: Chaorui surname: Huang fullname: Huang, Chaorui email: chh2019@med.cornell.edu – sequence: 2 givenname: Lisa D. surname: Ravdin fullname: Ravdin, Lisa D. – sequence: 3 givenname: Melissa J. surname: Nirenberg fullname: Nirenberg, Melissa J. – sequence: 4 givenname: Panida surname: Piboolnurak fullname: Piboolnurak, Panida – sequence: 5 givenname: Lawrence surname: Severt fullname: Severt, Lawrence – sequence: 6 givenname: James S. surname: Maniscalco fullname: Maniscalco, James S. – sequence: 7 givenname: Lilja surname: Solnes fullname: Solnes, Lilja – sequence: 8 givenname: Benjamin J. surname: Dorfman fullname: Dorfman, Benjamin J. – sequence: 9 givenname: Claire surname: Henchcliffe fullname: Henchcliffe, Claire |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27146872$$DView record in Pascal Francis |
BookMark | eNptkU1P3DAQhq2KqnyUA3cOvlQVhxTbcRK7N7Rl20pAkQqnqoom_giGxF7ZjsT-DX4x6S7lUHUuM6N53leamX2044M3CB1R8onSSp4SQkpeSdG8QXuUM1pIwfjOpiaFIETsov2U7mesqWr5Du2ykvNqjj30dGWmGNwIvfM9voT4YGLCweLLkEPE4DW-Cn7cNEsDeYpmM76eSedT8B8T_uKSgWQ-4zOPf1Gx_L0cphCDNuFx3Q-TCsng65BcjsHj89Gl5OZiEcbVlI3GN2EMfYTV3Rr_zJNev0dvLQzJHL7kA3S7PL9ZfCsufnz9vji7KFTJ61zUnW4kU3VZNV3NKVG6Am2BdZ0U0tqKU0Y6BUxa0DXVwlRC19wSLS0R1qryAH3Y-q4gKRhsBK9caldxvkZct6yhvBYNm7nTLadiSCka2yqXIc875AhuaClp_3yhff3CrDj5R_HX9H_s8ZZ9gNib-Eq-jJ8BHr-Tdg |
CitedBy_id | crossref_primary_10_1002_hbm_25110 crossref_primary_10_3389_fnagi_2016_00289 crossref_primary_10_26442_20751753_2022_2_201507 crossref_primary_10_1159_000351421 crossref_primary_10_1016_j_jns_2016_10_021 crossref_primary_10_1007_s00259_019_04570_7 crossref_primary_10_1186_s13550_017_0317_9 crossref_primary_10_3389_fneur_2019_01204 crossref_primary_10_1002_mds_29565 crossref_primary_10_18632_oncotarget_18996 crossref_primary_10_1016_j_media_2022_102378 crossref_primary_10_1016_j_neubiorev_2018_10_004 crossref_primary_10_1007_s11910_017_0788_0 crossref_primary_10_3389_fneur_2019_00195 crossref_primary_10_3389_fnhum_2020_00193 crossref_primary_10_3390_jpm11070679 crossref_primary_10_1093_braincomms_fcae025 crossref_primary_10_5692_clinicalneurol_cn_001709 crossref_primary_10_1007_s11682_017_9764_1 crossref_primary_10_1111_cns_14214 crossref_primary_10_1016_j_jns_2016_12_062 crossref_primary_10_1111_ene_13002 crossref_primary_10_1016_S1474_4422_15_00019_8 crossref_primary_10_1016_j_neulet_2017_05_062 crossref_primary_10_1371_journal_pone_0236728 crossref_primary_10_2478_cpp_2022_0021 crossref_primary_10_1186_s13195_024_01429_4 crossref_primary_10_1177_0891988719882100 crossref_primary_10_1093_brain_awy110 crossref_primary_10_1016_j_nicl_2018_08_006 crossref_primary_10_1016_j_jpsychires_2017_02_010 crossref_primary_10_1007_s11910_019_0966_3 crossref_primary_10_1038_s41598_020_79138_9 crossref_primary_10_1016_j_brs_2020_12_008 crossref_primary_10_1093_neuros_nyz206 crossref_primary_10_1016_j_neulet_2018_06_043 crossref_primary_10_1016_j_neuropsychologia_2017_07_003 crossref_primary_10_1016_j_brainres_2020_147235 crossref_primary_10_1016_j_cortex_2019_09_011 crossref_primary_10_1038_s41531_019_0102_8 crossref_primary_10_1016_j_neubiorev_2016_08_012 crossref_primary_10_1159_000455930 crossref_primary_10_3389_fnagi_2014_00056 crossref_primary_10_1016_S1474_4422_18_30169_8 crossref_primary_10_1002_mds_28372 crossref_primary_10_1007_s11682_018_9959_0 crossref_primary_10_1097_MD_0000000000029931 crossref_primary_10_1002_gps_5255 crossref_primary_10_3389_fnins_2020_00025 crossref_primary_10_17116_jnevro20161163179_82 crossref_primary_10_14336_AD_2018_0814 crossref_primary_10_1016_j_pneurobio_2018_12_003 crossref_primary_10_1002_mds_28404 crossref_primary_10_1016_S1634_7072_19_42021_7 crossref_primary_10_1002_mds_26349 crossref_primary_10_1155_2017_6219851 crossref_primary_10_1111_cns_12493 crossref_primary_10_1007_s11910_018_0907_6 crossref_primary_10_1093_brain_awy257 crossref_primary_10_1007_s40266_022_00942_1 crossref_primary_10_1002_mds_26662 crossref_primary_10_1016_j_jns_2015_06_037 crossref_primary_10_1002_mds_26587 crossref_primary_10_1016_j_jchemneu_2024_102392 crossref_primary_10_1155_2016_9832839 crossref_primary_10_3233_JPD_150535 |
Cites_doi | 10.1002%2Fmds.22833 10.1038%2Fnm0697-671 10.1159%2F000068483 10.1212%2FWNL.0b013e3182315259 10.1002%2Fmds.23268 10.1001%2Farchneur.60.12.1745 10.1002%2Fmds.21453 10.1097%2F00019052-199808000-00007 10.1016%2FS1474-4422%2809%2970293-5 10.1016%2F0022-3956%2875%2990026-6 10.1212%2FWNL.0b013e3181feb2ab 10.1097%2FNEN.0b013e31816362aa 10.1016%2Fj.pscychresns.2010.08.012 10.1016%2FS1053-8119%2803%2900168-X 10.1002%2Fmds.22760 10.1016%2Fj.jns.2011.07.006 10.1136%2Fjnnp.55.3.181 10.1159%2F000235247 10.1006%2Fnimg.2000.0582 10.1212%2F01.wnl.0000338632.00552.cb 10.1038%2Fjcbfm.1994.99 10.1212%2FWNL.0b013e3181f39d0e 10.1016%2Fj.parkreldis.2012.04.028 10.1016%2FS0022-510X%2899%2900127-6 10.1002%2Fmds.23664 10.1002%2Fmds.22611 10.1159%2F000315036 10.1007%2Fs13311-010-0007-z 10.1111%2Fj.1468-1331.2009.02707.x 10.1007%2Fs11910-011-0203-1 10.1016%2Fj.jns.2009.08.034 10.1002%2Fhbm.21378 10.1159%2F000323570 10.1212%2FWNL.0b013e3181c34b34 10.1002%2Fana.410280111 10.1212%2F01.wnl.0000269666.62598.1c 10.1097%2FWCO.0b013e32833b6019 10.1001%2Farchneur.64.7.1015 10.1002%2Fmds.10565 10.1093%2Fbrain%2Fawh445 10.1016%2FS1474-4422%2803%2900351-X 10.1093%2Fbrain%2Fawr031 10.1159%2F000336598 10.1007%2Fs00702-004-0168-1 10.1093%2Fbrain%2Fawm086 10.1177%2F0891988709351834 10.1192%2Fbjp.165.3.333 10.1136%2Fjnnp.2005.083113 10.1212%2F01.wnl.0000304050.05332.9c 10.1016%2F0165-1781%2891%2990040-V 10.1186%2F1471-2377-2-9 10.1212%2FWNL.0b013e3181a2e896 10.1007%2Fs00259-009-1259-x 10.1136%2Fjnnp.2006.100073 10.1093%2Fbrain%2F120.8.1315 10.1076%2Fclin.12.3.311.1992 |
ContentType | Journal Article |
Copyright | 2013 S. Karger AG, Basel 2014 INIST-CNRS |
Copyright_xml | – notice: 2013 S. Karger AG, Basel – notice: 2014 INIST-CNRS |
DBID | AAYXX CITATION IQODW |
DOI | 10.1159/000345987 |
DatabaseName | CrossRef Pascal-Francis |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1421-9824 |
EndPage | 196 |
ExternalDocumentID | 27146872 10_1159_000345987 345987 |
GroupedDBID | --- .GJ 0-V 0R~ 0~5 0~B 29F 30W 325 34G 36B 39C 3O. 3V. 4.4 53G 5GY 6PF 7RV 7X7 88E 88I 8AF 8AO 8FI 8FJ 8UI AAWTL AAYIC ABIVO ABJNI ABPAZ ABUWG ACGFS ACGOD ACPRK ACPSR ADAGL ADBBV ADGES AENEX AEYAO AFJJK AFKRA AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI AN0 ARALO AZPMC AZQEC BENPR BKEYQ BNQBC BPHCQ BVXVI CAG CCPQU COF CS3 CYUIP DU5 DWQXO E0A EBS EJD EMB EMOBN EX3 F5P FB. FYUFA GNUQQ HCIFZ HMCUK HZ~ IAO IHR IHW IY7 KUZGX M1P M2M M2P M2R N9A NAPCQ O1H O9- P2P PQQKQ PROAC PSQYO PSYQQ RIG RKO RXVBD S0X SV3 UJ6 UKHRP WOW AAYXX ABBTS ABWCG ACQXL AFSIO AHFRZ CITATION ITC PHGZM PHGZT IQODW |
ID | FETCH-LOGICAL-c346t-6bd792c6357b6410cd5adfa2bb989ff54120bca29fad61d8e58d64f0d9f08ffc3 |
ISSN | 1420-8008 |
IngestDate | Wed Apr 02 07:25:18 EDT 2025 Tue Jul 01 05:07:41 EDT 2025 Thu Apr 24 23:11:20 EDT 2025 Thu Aug 29 12:04:44 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3-4 |
Keywords | Glucose metabolism Nonmotor features of Parkinson's disease Cognition Parkinson's disease Emotion Positron emission tomography 2-deoxy-2-fluoroglucose Nervous system diseases Cognitive disorder Parkinson disease Glucose Metabolism Cerebral disorder Central nervous system disease Degenerative disease Extrapyramidal syndrome Dementia Emission tomography |
Language | English |
License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. https://www.karger.com/Services/SiteLicenses CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c346t-6bd792c6357b6410cd5adfa2bb989ff54120bca29fad61d8e58d64f0d9f08ffc3 |
PMID | 23445555 |
PageCount | 14 |
ParticipantIDs | crossref_citationtrail_10_1159_000345987 pascalfrancis_primary_27146872 karger_primary_345987 crossref_primary_10_1159_000345987 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-01-01 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – month: 01 year: 2013 text: 2013-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Basel |
PublicationTitle | Dementia and geriatric cognitive disorders |
PublicationTitleAlternate | Dement Geriatr Cogn Disord |
PublicationYear | 2013 |
Publisher | Karger |
Publisher_xml | – name: Karger |
References | Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK: Striatal beta-amyloid deposition in Parkinson disease with dementia. J Neuropathol Exp Neurol 2008;67:155-161.1821925410.1097%2FNEN.0b013e31816362aa Benoit M, Robert PH: Imaging correlates of apathy and depression in Parkinson's disease. J Neurol Sci 2011;310:58-60.2183140010.1016%2Fj.jns.2011.07.006 Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA: Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 2009;8:1128-1139.1990991110.1016%2FS1474-4422%2809%2970293-5 Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S: The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994;14:783-801.806387410.1038%2Fjcbfm.1994.99 Bosboom JL, Stoffers D, Wolters E: Cognitive dysfunction and dementia in Parkinson's disease. J Neural Transm 2004;111:1303-1315.1548084010.1007%2Fs00702-004-0168-1 Reitan RRM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, Neuropsychology Press, 1992. Huang C, Wahlund LO, Almkvist O, Elehu D, Svensson L, Jonsson T, Winblad B, Julin P: Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage 2003;19:1137-1144.1288083910.1016%2FS1053-8119%2803%2900168-X Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G: Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009;72:1121-1126.1902029310.1212%2F01.wnl.0000338632.00552.cb Lyoo CH, Jeong Y, Ryu YH, Rinne JO, Lee MS: Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment. Eur Neurol 2010;64:65-73.2060645010.1159%2F000315036 Marin R, Biedrzycki RC, Firinciogullari S: Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991;38:143-162.175462910.1016%2F0165-1781%2891%2990040-V Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, Wiley, 1989. Stoessl AJ: Neuroimaging in Parkinson's disease. Neurotherapeutics 2011;8:72-81.2127468710.1007%2Fs13311-010-0007-z Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D: Changes in network activity with the progression of Parkinson's disease. Brain 2007;130:1834-1846.1747049510.1093%2Fbrain%2Fawm086 Wechsler D: Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) 1997; San Antonio, TX: The Psychological Corporation. Appel-Cresswell S, de la Fuente-Fernandez R, Galley S, McKeown MJ: Imaging of compensatory mechanisms in Parkinson's disease. Curr Opin Neurol 2010;23:407-412.2061099110.1097%2FWCO.0b013e32833b6019 Le Jeune F, Drapier D, Bourguignon A, Peron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B Verin M: Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 2009;73:1746-1751.1993397510.1212%2FWNL.0b013e3181c34b34 Goldon C: Stroop Color and Word Test. Chicago, Stoelting Company, 1978. Berti V, Polito C, Ramat S, Vanzi E, De Cristofaro MT, Pellicano G, Mungai F, Marini P, Formiconi AR, Sorbi S, Pupi A: Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging 2010;37:537-544.1972771210.1007%2Fs00259-009-1259-x Fahn S, Elton R, the Members of the Unified Parkinson's Disease Rating Scale Development Commitee: Unified Parkinson's Disease Rating Scale; in Fahn CD, Calne DB, Goldstein M (eds): Recent Developments in Parkinson's Disease. New York, MacMillan, 1987. Beck AT, Steer RA: Beck Anxiety Inventory Manual. San Antonio, The Psychological Corporation, 1990. Kaplan E, Goodglass H, Weintraub S: The Boston Naming Test. Boston, Kaplan and Goodglass, 1978. Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junque C, Bargallo N, Tolosa E: Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp 2012;33:2521-2534.2189867910.1002%2Fhbm.21378 Politis M, Wu K, Loane C, Turkheimer FE, Molloy S, Brooks DJ, Piccini P: Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 2010;75:1920-1927.2109840710.1212%2FWNL.0b013e3181feb2ab Remy P, Doder M, Lees A, Turjanski N, Brooks D: Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314-1322.1571630210.1093%2Fbrain%2Fawh445 Huang C, Wahlund LO, Svensson L, Winblad B, Julin P: Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol 2002;2:9.1222783310.1186%2F1471-2377-2-9 Broussolle E, Dentresangle C, Landais P, Garcia-Larrea L, Pollak P, Croisile B, Hibert O, Bonnefoi F, Galy G, Froment JC, Comar D: The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci 1999;166:141-151.1047510810.1016%2FS0022-510X%2899%2900127-6 Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M: Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010;75:1062-1069.2085584910.1212%2FWNL.0b013e3181f39d0e Compta Y, Ibarretxe-Bilbao N, Pereira JB, Junque C, Bargallo N, Tolosa E, Valldeoriola F, Munoz E, Camara A, Buongiorno M, Marti MJ: Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia. Parkinsonism Relat Disord 2012;18:941-947.2259562110.1016%2Fj.parkreldis.2012.04.028 Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, Spetsieris P, Alterman R, Kelly PJ, Dogali M, Fazzini E, Beric A: Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 1997;120:1315-1324.927862510.1093%2Fbrain%2F120.8.1315 Emre M: Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229-237.1284921110.1016%2FS1474-4422%2803%2900351-X Dissanayaka NN, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD: Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2010;25:838-845.2046180010.1002%2Fmds.22833 Janvin C, Aarsland D, Larsen JP, Hugdahl K: Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003;15:126-131.1258442710.1159%2F000068483 Aarsland D, Kurz MW: The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 2010;289:18-22.1973336410.1016%2Fj.jns.2009.08.034 Beyer MK, Larsen JP, Aarsland D: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 2007;69:747-754.1770970610.1212%2F01.wnl.0000269666.62598.1c Benton AL, Hamsher K, Sivan AB: Manual for the Multilingual Aphasia Examination, ed 3. Iowa City, AJA Associates, Inc, 1994. Saur R, Maier C, Milian M, Riedel E, Berg D, Liepelt-Scarfone I, Leyhe T: Clock test deficits related to the global cognitive state in Alzheimer's and Parkinson's disease. Dement Geriatr Cogn Disord 2012;33:59-72.2241521110.1159%2F000336598 Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RS, Dolan RJ: Depression in Parkinson's disease. A positron emission study. Br J Psychiatry 1994;165:333-339.799450210.1192%2Fbjp.165.3.333 Oguru M, Tachibana H, Toda K, Okuda B, Oka N: Apathy and depression in Parkinson disease. J Geriatr Psychiatry Neurol 2010;23:35-41.2001583910.1177%2F0891988709351834 Aarsland D, Bronnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL: Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007;78:36-42.1682042110.1136%2Fjnnp.2005.083113 Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.156447610.1136%2Fjnnp.55.3.181 Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL: Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol 2007;64:1015-1020.1762049310.1001%2Farchneur.64.7.1015 Winegarden BJ, Yates BL, Moses JJA, Benton AL, Faustman WO: Development of an optimally reliable short form for judgment of line orientation. Clin Neuropsychol 1998;12:311-314.10.1076%2Fclin.12.3.311.1992 Weintraub D, Burn DJ: Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011;26:1022-1031.2162654710.1002%2Fmds.23664 Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH: Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1272-1277.1741579710.1002%2Fmds.21453 Beck AT, Steer RA, Brown GK: Beck Depression Inventory, ed 2. San Antonio, The Psychological Corporation, 1996. Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, Wagner HN Jr, Robinson RG: Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64.237563410.1002%2Fana.410280111 Reijnders JS, Scholtissen B, Weber WE, Aalten P, Verhey FR, Leentjens AF: Neuroanatomical correlates of apathy in Parkinson's disease: a magnetic resonance imaging study using voxel-based morphometry. Mov Disord 2010;25:2318-2325.2066926410.1002%2Fmds.23268 Johnson DK, Galvin JE: Longitudinal changes in cognition in Parkinson's disease with and without dementia. Dement Geriatr Cogn Disord 2011;31:98-108.2124269110.1159%2F000323570 Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D: Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 2008;70:1470-1477.1836770510.1212%2F01.wnl.0000304050.05332.9c Frisoni GB, Lorenzi M, Caroli ref13 ref12 ref56 ref15 ref14 ref53 ref52 ref11 ref55 ref10 ref54 ref17 ref16 ref19 ref18 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 ref1 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 |
References_xml | – reference: Berti V, Polito C, Ramat S, Vanzi E, De Cristofaro MT, Pellicano G, Mungai F, Marini P, Formiconi AR, Sorbi S, Pupi A: Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging 2010;37:537-544.1972771210.1007%2Fs00259-009-1259-x – reference: Reijnders JS, Scholtissen B, Weber WE, Aalten P, Verhey FR, Leentjens AF: Neuroanatomical correlates of apathy in Parkinson's disease: a magnetic resonance imaging study using voxel-based morphometry. Mov Disord 2010;25:2318-2325.2066926410.1002%2Fmds.23268 – reference: Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH: Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1272-1277.1741579710.1002%2Fmds.21453 – reference: McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D: Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease. Dement Geriatr Cogn Disord 2009;28:121-129.1969041410.1159%2F000235247 – reference: Fahn S, Elton R, the Members of the Unified Parkinson's Disease Rating Scale Development Commitee: Unified Parkinson's Disease Rating Scale; in Fahn CD, Calne DB, Goldstein M (eds): Recent Developments in Parkinson's Disease. New York, MacMillan, 1987. – reference: Johnson DK, Galvin JE: Longitudinal changes in cognition in Parkinson's disease with and without dementia. Dement Geriatr Cogn Disord 2011;31:98-108.2124269110.1159%2F000323570 – reference: Elgh E, Domellof M, Linder J, Edstrom M, Stenlund H, Forsgren L: Cognitive function in early Parkinson's disease: a population-based study. Eur J Neurol 2009;16:1278-1284.1953820810.1111%2Fj.1468-1331.2009.02707.x – reference: Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D: Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 2008;70:1470-1477.1836770510.1212%2F01.wnl.0000304050.05332.9c – reference: Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, Wagner HN Jr, Robinson RG: Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64.237563410.1002%2Fana.410280111 – reference: Winegarden BJ, Yates BL, Moses JJA, Benton AL, Faustman WO: Development of an optimally reliable short form for judgment of line orientation. Clin Neuropsychol 1998;12:311-314.10.1076%2Fclin.12.3.311.1992 – reference: Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.120220410.1016%2F0022-3956%2875%2990026-6 – reference: Apostolova I, Block S, Buchert R, Osen B, Conradi M, Tabrizian S, Gensichen S, Schroder-Hartwig K, Fricke S, Rufer M, Weiss A, Hand I, Clausen M, Obrocki J: Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET. Psychiatry Res 2010;184:105-116.2094731710.1016%2Fj.pscychresns.2010.08.012 – reference: Goldon C: Stroop Color and Word Test. Chicago, Stoelting Company, 1978. – reference: Blonder LX, Slevin JT: Emotional dysfunction in Parkinson's disease. Behav Neurol 2011;24:201-217.21876260 – reference: Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK: Striatal beta-amyloid deposition in Parkinson disease with dementia. J Neuropathol Exp Neurol 2008;67:155-161.1821925410.1097%2FNEN.0b013e31816362aa – reference: Weintraub D, Burn DJ: Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011;26:1022-1031.2162654710.1002%2Fmds.23664 – reference: Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T: Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain 2011;134:1493-505.2159677310.1093%2Fbrain%2Fawr031 – reference: Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA: Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 2009;8:1128-1139.1990991110.1016%2FS1474-4422%2809%2970293-5 – reference: Huang C, Wahlund LO, Svensson L, Winblad B, Julin P: Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol 2002;2:9.1222783310.1186%2F1471-2377-2-9 – reference: Beck AT, Steer RA: Beck Anxiety Inventory Manual. San Antonio, The Psychological Corporation, 1990. – reference: Remy P, Doder M, Lees A, Turjanski N, Brooks D: Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314-1322.1571630210.1093%2Fbrain%2Fawh445 – reference: Le Jeune F, Drapier D, Bourguignon A, Peron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B Verin M: Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 2009;73:1746-1751.1993397510.1212%2FWNL.0b013e3181c34b34 – reference: Janvin C, Aarsland D, Larsen JP, Hugdahl K: Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003;15:126-131.1258442710.1159%2F000068483 – reference: Frisoni GB, Lorenzi M, Caroli A, Kemppainen N, Nagren K, Rinne JO: In vivo mapping of amyloid toxicity in Alzheimer disease. Neurology 2009;72:1504-1511.1939870510.1212%2FWNL.0b013e3181a2e896 – reference: Reitan RRM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, Neuropsychology Press, 1992. – reference: Emre M: Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229-237.1284921110.1016%2FS1474-4422%2803%2900351-X – reference: Lyoo CH, Jeong Y, Ryu YH, Rinne JO, Lee MS: Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment. Eur Neurol 2010;64:65-73.2060645010.1159%2F000315036 – reference: Smith A: Symbol Digit Modalities Test (SDMT) Manual (Revised). Los Angeles, Western Psychological Services, 1982. – reference: Aarsland D, Bronnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL: Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007;78:36-42.1682042110.1136%2Fjnnp.2005.083113 – reference: Aarsland D, Bronnick K, Fladby T: Mild cognitive impairment in Parkinson's disease. Curr Neurol Neurosci Rep 2011;11:371-378.2148773010.1007%2Fs11910-011-0203-1 – reference: Aarsland D, Kurz MW: The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 2010;289:18-22.1973336410.1016%2Fj.jns.2009.08.034 – reference: Goodglass H, Kaplan E: Assessment of Aphasia and Related Disorders, ed 2. Philadelphia, Lea and Febiger, 1983. – reference: Beyer MK, Larsen JP, Aarsland D: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 2007;69:747-754.1770970610.1212%2F01.wnl.0000269666.62598.1c – reference: Beck AT, Steer RA, Brown GK: Beck Depression Inventory, ed 2. San Antonio, The Psychological Corporation, 1996. – reference: Negre-Pages L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lepine JP, Rascol O: Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Mov Disord 2010;25:157-166.1995040310.1002%2Fmds.22760 – reference: Saur R, Maier C, Milian M, Riedel E, Berg D, Liepelt-Scarfone I, Leyhe T: Clock test deficits related to the global cognitive state in Alzheimer's and Parkinson's disease. Dement Geriatr Cogn Disord 2012;33:59-72.2241521110.1159%2F000336598 – reference: Appel-Cresswell S, de la Fuente-Fernandez R, Galley S, McKeown MJ: Imaging of compensatory mechanisms in Parkinson's disease. Curr Opin Neurol 2010;23:407-412.2061099110.1097%2FWCO.0b013e32833b6019 – reference: Bohnen NI, Kaufer DI, Hendrickson R, Constantine GM, Mathis CA, Moore RY: Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia. J Neurol Neurosurg Psychiatry 2007;78:641-643.1750744710.1136%2Fjnnp.2006.100073 – reference: Broussolle E, Dentresangle C, Landais P, Garcia-Larrea L, Pollak P, Croisile B, Hibert O, Bonnefoi F, Galy G, Froment JC, Comar D: The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci 1999;166:141-151.1047510810.1016%2FS0022-510X%2899%2900127-6 – reference: Politis M, Wu K, Loane C, Turkheimer FE, Molloy S, Brooks DJ, Piccini P: Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 2010;75:1920-1927.2109840710.1212%2FWNL.0b013e3181feb2ab – reference: Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D: Changes in network activity with the progression of Parkinson's disease. Brain 2007;130:1834-1846.1747049510.1093%2Fbrain%2Fawm086 – reference: Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M: Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010;75:1062-1069.2085584910.1212%2FWNL.0b013e3181f39d0e – reference: Pappata S, Santangelo G, Aarsland D, Vicidomini C, Longo K, Bronnick K, Amboni M, Erro R, Vitale C, Caprio MG, Pellecchia MT, Brunetti A, De Michele G, Salvatore M, Barone P: Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. Neurology 2011;77:1357-1362.2194062110.1212%2FWNL.0b013e3182315259 – reference: Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S: The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994;14:783-801.806387410.1038%2Fjcbfm.1994.99 – reference: Benoit M, Robert PH: Imaging correlates of apathy and depression in Parkinson's disease. J Neurol Sci 2011;310:58-60.2183140010.1016%2Fj.jns.2011.07.006 – reference: Benton AL, Hamsher K, Sivan AB: Manual for the Multilingual Aphasia Examination, ed 3. Iowa City, AJA Associates, Inc, 1994. – reference: Emre M: What causes mental dysfunction in Parkinson's disease? Mov Disord 2003;18(suppl 6):S63-S71.1450265810.1002%2Fmds.10565 – reference: Oguru M, Tachibana H, Toda K, Okuda B, Oka N: Apathy and depression in Parkinson disease. J Geriatr Psychiatry Neurol 2010;23:35-41.2001583910.1177%2F0891988709351834 – reference: Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL: Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol 2007;64:1015-1020.1762049310.1001%2Farchneur.64.7.1015 – reference: Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, Spetsieris P, Alterman R, Kelly PJ, Dogali M, Fazzini E, Beric A: Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 1997;120:1315-1324.927862510.1093%2Fbrain%2F120.8.1315 – reference: Ashburner J, Friston KJ: Voxel-based morphometry - the methods. Neuroimage 2000;11:805-821.1086080410.1006%2Fnimg.2000.0582 – reference: Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G: Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2009;72:1121-1126.1902029310.1212%2F01.wnl.0000338632.00552.cb – reference: Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L: Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord 2009;24:1333-1338.1942508610.1002%2Fmds.22611 – reference: Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.156447610.1136%2Fjnnp.55.3.181 – reference: Dissanayaka NN, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD: Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2010;25:838-845.2046180010.1002%2Fmds.22833 – reference: Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, Wiley, 1989. – reference: Compta Y, Ibarretxe-Bilbao N, Pereira JB, Junque C, Bargallo N, Tolosa E, Valldeoriola F, Munoz E, Camara A, Buongiorno M, Marti MJ: Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia. Parkinsonism Relat Disord 2012;18:941-947.2259562110.1016%2Fj.parkreldis.2012.04.028 – reference: Wechsler D: Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) 1997; San Antonio, TX: The Psychological Corporation. – reference: Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junque C, Bargallo N, Tolosa E: Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp 2012;33:2521-2534.2189867910.1002%2Fhbm.21378 – reference: Bosboom JL, Stoffers D, Wolters E: Cognitive dysfunction and dementia in Parkinson's disease. J Neural Transm 2004;111:1303-1315.1548084010.1007%2Fs00702-004-0168-1 – reference: Huang C, Wahlund LO, Almkvist O, Elehu D, Svensson L, Jonsson T, Winblad B, Julin P: Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage 2003;19:1137-1144.1288083910.1016%2FS1053-8119%2803%2900168-X – reference: Turner RS, Grafton ST, Votaw JR, Delong MR, Hoffman JM: Motor subcircuits mediating the control of movement velocity: a PET study. J Neurophysiol 1998;80:2162-2176.9772269 – reference: Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, Mathis CA, Moore RY, DeKosky ST: Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 2003;60:1745-1748.1467605010.1001%2Farchneur.60.12.1745 – reference: Delis DC, Kramer J, Kaplan E, Ober B: The California Verbal Learning Test, ed 2. San Antonio, The Psychological Corporation, 2000. – reference: Kaplan E, Goodglass H, Weintraub S: The Boston Naming Test. Boston, Kaplan and Goodglass, 1978. – reference: Marin R, Biedrzycki RC, Firinciogullari S: Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991;38:143-162.175462910.1016%2F0165-1781%2891%2990040-V – reference: Mattis S: Dementia Rating Scale. Odessa, The Psychological Corporation, 1988. – reference: Eidelberg D: Functional brain networks in movement disorders. Curr Opin Neurol 1998;11:319-326.972507710.1097%2F00019052-199808000-00007 – reference: Stoessl AJ: Neuroimaging in Parkinson's disease. Neurotherapeutics 2011;8:72-81.2127468710.1007%2Fs13311-010-0007-z – reference: Davis KD, Taub E, Houle S, Lang AE, Dostrovsky JO, Tasker RR, Lozano AM: Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med 1997;3:671-674.917649510.1038%2Fnm0697-671 – reference: Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RS, Dolan RJ: Depression in Parkinson's disease. A positron emission study. Br J Psychiatry 1994;165:333-339.799450210.1192%2Fbjp.165.3.333 – ident: ref44 doi: 10.1002%2Fmds.22833 – ident: ref21 doi: 10.1038%2Fnm0697-671 – ident: ref14 doi: 10.1159%2F000068483 – ident: ref24 doi: 10.1212%2FWNL.0b013e3182315259 – ident: ref53 doi: 10.1002%2Fmds.23268 – ident: ref47 doi: 10.1001%2Farchneur.60.12.1745 – ident: ref10 doi: 10.1002%2Fmds.21453 – ident: ref56 doi: 10.1097%2F00019052-199808000-00007 – ident: ref1 doi: 10.1016%2FS1474-4422%2809%2970293-5 – ident: ref30 doi: 10.1016%2F0022-3956%2875%2990026-6 – ident: ref48 doi: 10.1212%2FWNL.0b013e3181feb2ab – ident: ref41 doi: 10.1097%2FNEN.0b013e31816362aa – ident: ref51 doi: 10.1016%2Fj.pscychresns.2010.08.012 – ident: ref55 doi: 10.1016%2FS1053-8119%2803%2900168-X – ident: ref50 doi: 10.1002%2Fmds.22760 – ident: ref52 doi: 10.1016%2Fj.jns.2011.07.006 – ident: ref29 doi: 10.1136%2Fjnnp.55.3.181 – ident: ref13 doi: 10.1159%2F000235247 – ident: ref33 doi: 10.1006%2Fnimg.2000.0582 – ident: ref9 doi: 10.1212%2F01.wnl.0000338632.00552.cb – ident: ref20 doi: 10.1038%2Fjcbfm.1994.99 – ident: ref3 doi: 10.1212%2FWNL.0b013e3181f39d0e – ident: ref35 doi: 10.1016%2Fj.parkreldis.2012.04.028 – ident: ref37 doi: 10.1016%2FS0022-510X%2899%2900127-6 – ident: ref6 doi: 10.1002%2Fmds.23664 – ident: ref43 doi: 10.1002%2Fmds.22611 – ident: ref25 doi: 10.1159%2F000315036 – ident: ref19 doi: 10.1007%2Fs13311-010-0007-z – ident: ref11 doi: 10.1111%2Fj.1468-1331.2009.02707.x – ident: ref12 doi: 10.1007%2Fs11910-011-0203-1 – ident: ref8 doi: 10.1016%2Fj.jns.2009.08.034 – ident: ref34 doi: 10.1002%2Fhbm.21378 – ident: ref16 doi: 10.1159%2F000323570 – ident: ref28 doi: 10.1212%2FWNL.0b013e3181c34b34 – ident: ref26 doi: 10.1002%2Fana.410280111 – ident: ref36 doi: 10.1212%2F01.wnl.0000269666.62598.1c – ident: ref39 doi: 10.1097%2FWCO.0b013e32833b6019 – ident: ref54 doi: 10.1001%2Farchneur.64.7.1015 – ident: ref2 doi: 10.1002%2Fmds.10565 – ident: ref49 doi: 10.1093%2Fbrain%2Fawh445 – ident: ref4 doi: 10.1016%2FS1474-4422%2803%2900351-X – ident: ref42 doi: 10.1093%2Fbrain%2Fawr031 – ident: ref7 doi: 10.1159%2F000336598 – ident: ref15 doi: 10.1007%2Fs00702-004-0168-1 – ident: ref17 doi: 10.1093%2Fbrain%2Fawm086 – ident: ref45 doi: 10.1177%2F0891988709351834 – ident: ref27 doi: 10.1192%2Fbjp.165.3.333 – ident: ref5 doi: 10.1136%2Fjnnp.2005.083113 – ident: ref23 doi: 10.1212%2F01.wnl.0000304050.05332.9c – ident: ref32 doi: 10.1016%2F0165-1781%2891%2990040-V – ident: ref38 doi: 10.1186%2F1471-2377-2-9 – ident: ref40 doi: 10.1212%2FWNL.0b013e3181a2e896 – ident: ref22 doi: 10.1007%2Fs00259-009-1259-x – ident: ref46 doi: 10.1136%2Fjnnp.2006.100073 – ident: ref18 doi: 10.1093%2Fbrain%2F120.8.1315 – ident: ref31 doi: 10.1076%2Fclin.12.3.311.1992 |
SSID | ssj0007569 |
Score | 2.348333 |
Snippet | Aim: We sought to identify markers of motor and nonmotor function in Parkinson's disease (PD) using advanced neuroimaging techniques in subjects with PD.... |
SourceID | pascalfrancis crossref karger |
SourceType | Index Database Enrichment Source Publisher |
StartPage | 183 |
SubjectTerms | Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Investigative techniques, diagnostic techniques (general aspects) Medical sciences Nervous system Neurology Original Research Article Radionuclide investigations |
Title | Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography Study |
URI | https://karger.com/doi/10.1159/000345987 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9NAFB7KKuKL6LrielkGcVehW23SmVx8S7ctrWvTUrZSWKQkmYwston0Ataf4d_yT3nmkknrLnh5CW0yNEnPl5lzTr7zHYRecjdibiOGMBXQUCOObdW8lCa1yPJ8h3IScdm1pB863TF5P6GTSuXnFmtpvYrfJN9vrCv5H6vCPrCrqJL9B8uaH4Ud8BnsC1uwMGz_ysZSWeNqrhoNiaobUY0rOC35SnMjwzybyy_C1VsvlMKsqHTWRV_uUuhvilc0OkN4TJuW1zmmrc5sncPkmubfNgWtfSgIXguASxvAIbJsVd0TQrBx5lr7WjITd94Vt2QGUhV_VT-L_0V0BaiWxCWmFUCNe3_WDQajca_aHQeh6f01Cj62eqHKIyyjkqkc9kbtsNkeydqrfjqDS4vKl13DXnMw-BCOR8G5cpizK52D0KkO0XZiJ9VxLrjxi63JmkDoCw6vtz2bK_ETjdqigkhNzpZqmaPXeUt10r2-hFBfcS4bhPraGdiR6f5t-TSkRtsVZWwu-AO3bIhZRDsNd2Kif3DNZH9Fc9Fa5gpO99acbMc5uv1F3q9g60ZLeGC56rSy5f5c3Ef3dNyCAwXCB6iSZvvoTl8zM_bRyVBpoG9O8UVZ0rc8xSd4WKqjbx6iH9ugxRq0OOdYghYDRnABWlyAVhw2oH21xBqy73CQ4UuA66frYMUFWHEBVlyAFZdgxRKsB2jcaV-cdWu6MUgtaRBnVXNi5vp2IqQUY4dY9YTRiPHIjmPf8zmnxLLrcRLZPo-YYzGYfDzmEF5nPq97nCeNR2gvy7P0McKuQ2JweX3mWYT4nMUND2JOltAU_HRO64fodWGRaaJV80XzltlURs_UnxrjHaIXZuhXJRVz06ADZVYzpNh_tGNlc7hA1ZM_DXiK7pbPzDO0t1qs0-fgMK_iIwnEXz9yxGQ |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neuroimaging+Markers+of+Motor+and+Nonmotor+Features+of+Parkinson%27s+Disease%3A+An+%5B18F%5DFluorodeoxyglucose+Positron+Emission+Computed+Tomography+Study&rft.jtitle=Dementia+and+geriatric+cognitive+disorders&rft.au=CHAORUI+HUANG&rft.au=RAVDIN%2C+Lisa+D&rft.au=NIRENBERG%2C+Melissa+J&rft.au=PIBOOLNURAK%2C+Panida&rft.date=2013-01-01&rft.pub=Karger&rft.issn=1420-8008&rft.volume=35&rft.issue=3-4&rft.spage=183&rft.epage=196&rft_id=info:doi/10.1159%2F000345987&rft.externalDBID=n%2Fa&rft.externalDocID=27146872 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-8008&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-8008&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-8008&client=summon |